Skip to main content

Table 1 Practical recommendations

From: Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus

Identification of only one clinical referent in each center

Necessity of comprehensive multidisciplinary assessment

Regular monitoring of pre-symptomatic ten years before PADO

Taking in charge newly identified pre-symptomatic carriers

Specific psychological support after pre-symptomatic testing in selected cases

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172